Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes are wafting across the Pharmalot campus, where the official mascots are foraging for their breakfast and rousing the neighbors. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is cinnamon vanilla. As always, we invite you to join us. Meanwhile, here is the latest menu of tidbits to help you get started yourself. We hope...

Roche plans to invest $50 billion in the U.S. over the next five years, joining Swiss rival Novartis in expanding its footprint in the country amid President Trump’s tariff threats.

The Swiss pharma giant said Tuesday that the investment includes new research hubs and new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California. The company said that investment would create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities.